In silico approach for the development of novel antiviral compounds based on SARS-COV-2 protease inhibition.
Vanja P NičkčovićGordana R NikolićBiserka M NedeljkovićNebojša MitićSnežana Filipović DanićJadranka MitićZoran MarčetićDušan SokolovićAleksandar M VeselinovićPublished in: Chemicke zvesti (2022)
The online version contains supplementary material available at 10.1007/s11696-022-02170-8.